Key Record Dates
ClinicalTrials.gov Identifier: | NCT04684940 |
---|---|
Brief Title: | Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors (GENEr8-INH) |
First Submitted : | November 30, 2020 |
First Submitted that Met QC Criteria : | December 24, 2020 |
First Posted : | December 28, 2020 |
Last Update Submitted that Met QC Criteria : | April 22, 2024 |
Last Update Posted : | April 24, 2024 |